Delivery Order SPE2DB22D1106-SPE2DB25FEVE3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,867.58 to AmerisourceBergen Drug Corp for the supply of Lidocaine 2% Viscous Solution in 100ml quantities. This contract, awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a firm fixed-price procurement with no set-aside designation. The award was competitively executed and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,020.48 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution in 50ml units. This firm fixed-price delivery order, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $2,030.80 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lidocaine 2% Viscous in 15 ML cup unit dose format. This non-set-aside, firm fixed price contract is scheduled for completion by July 30, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $1,387.67 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Lidocaine 0.8% in D5W Solution in 250ml units. The delivery order, with an ultimate completion date of July 25, 2025, represents a single-day fulfillment requirement for this pharmaceutical product. This award was made without a set-aside designation, indicating it was competitively awarded through open procurement processes. The place of performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 2% 100 mg/5 mL vials, with a contract ceiling value of $1,097.24. The award was issued on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency Troop Support Medical awarded a $2,399.04 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 milliliters of 2% viscous lidocaine solution. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for a single day's supply to fulfill an immediate need, with performance required between August 1st and 2nd, 2023. As a major medical distributor, Amerisourcebergen routinely supports the Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,437.99 to AmerisourceBergen Drug Corp for Lidocaine HCL 1% vials (10 mL) on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes firm fixed pricing with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,010.94 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lidocaine HCL 4% Solution in 4ML vials, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,809.06 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 50ML (25 units) with an ultimate completion date of September 29, 2025. This competitive award, issued on September 2, 2025, carries firm fixed pricing and involves no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a $1,903.04 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 ml vials (5 ml). This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEVE3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 2% Viscous Solution 100ML under a firm fixed-price contract valued at $6,361.57. The contract was awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen regularly supplies medications and medical supplies to support military and veteran healthcare systems. The firm fixed-price delivery order structure and competitive award process demonstrate the contractor's established capability to meet federal healthcare procurement requirements through the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 6/25/25 |